[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370670-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370670-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","risk-factors-for-cancer-among-patients-with-type-2-diabetes-a-retrospective-cohort-study","Risk factors for cancer among patients with type 2 diabetes - a retrospective cohort study","","Type 2 diabetes mellitus and cancer create major global public-health burdens. A retrospective cohort study used electronic medical records to describe cancer case distribution and assess associated risk factors in adults with T2DM. Among 3,284 included patients followed for a median of 27 months, 467 developed cancer, with digestive system cancers predominating. Multivariable Cox models identified lower serum uric acid and a higher AST/ALT ratio as key risk factors, with additional factors varying by cancer type. Findings support targeted cancer screening in high-risk T2DM patients while requiring prospective validation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/risk-factors-for-cancer-among-patients-with-type-2-diabetes-a-retrospective-cohort-study/370670/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/risk-factors-for-cancer-among-patients-with-type-2-diabetes-a-retrospective-cohort-study/370670.png","ImageObject",300,407,{"name":42,"@type":43},"Putri","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the goal of the retrospective cohort study?","Question",{"text":63,"@type":64},"To investigate how cancer cases are distributed among patients with type 2 diabetes and identify associated risk factors that could inform clinical practice.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many T2DM patients were analyzed, and how long were they followed?",{"text":68,"@type":64},"Electronic medical records of 70,073 patients were screened; 3,284 were included after exclusions, with a median follow-up of 27 months.",{"name":70,"@type":61,"acceptedAnswer":71},"Which biomarkers were linked to cancer risk in the multivariable analysis?",{"text":72,"@type":64},"Lower serum uric acid levels and a higher AST/ALT ratio were associated with cancer risk among T2DM patients, with cancer-type-specific factors also reported.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370670,1790706607,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Liu et al. BMC Cancer (2025) 25:1059 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-14483-4](https://doi.org/10.1186/s12885-025-14483-4)  \nRESEARCH Open Access  \nRisk factors for cancer among patients with type 2 diabetes: a retrospective cohort study  \nHui Liu 1,2, Tian-Yi Zhang 1,2, Ya-Wen Wang 1,2 and Juan-Juan Gao 1,2*  \nAbstract  \nBackground Type 2 diabetes mellitus (T2DM) and cancer pose significant public health challenges worldwide. This study investigated the distribution of cancer cases and associated risk factors among patients with T2DM, aiming to inform clinical practices and reduce the burden of co-morbidities.  \nMethods A retrospective cohort study analyzed electronic medical records of 70,073 T2DM patients admitted between 2013 and 2019. After exclusions, 3,284 individuals were included, with a median follow-up of 27 months. Associations between 38 baseline characteristics and cancer risk were first assessed using univariate Cox proportional hazards models (reported as hazard ratios [HRs] with 95% confidence intervals [CIs]) . Significant predictors (p \u003C 0. 05) were further analyzed in adjusted multivariable Cox models by backward elimination (retaining 2 significant covariates) .  \nResults Among the participants, 467 (14 . 2%) developed cancer, with digestive system cancers being the most prevalent (5 . 8%) . The median age of participants was 58 years, with 59% being male. Risk factors for cancer among T2DM patients identified in multivariate analysis included lower serum uric acid levels (HR: 0 . 9970, 95% CI: 0.9942– 0. 9998), and higher AST/ALT ratio (HR: 1. 84, 95% CI: 1.16–2. 92) . Specific risk factors for different types of cancer were also identified, such as lower apolipoprotein A for digestive system cancers and older age and lower serum uric acid levels for lung cancer.  \nConclusions These findings highlight the potential value of integrating cancer screening into T2DM management for high-risk patients, such as individuals with altered uric acid or liver enzyme profiles. However, the study’s retrospective design and reliance on single-center data necessitate further prospective studies to validate these associations and refine biomarker-guided monitoring strategies.  \nKeywords Neoplasms, Diabetes mellitus, type 2, Risk factors, Biomarkers, Retrospective cohort study  \n*Correspondence:  \nJuan-Juan Gao  \n[juan_gao2018@xjtu.edu.cn](juan_gao2018@xjtu.edu.cn)  \n1Biobank, The First Affiliated Hospital of Xi ’an Jiaotong University, Xi’an, Shaanxi 710061, China  \n2Shaanxi Engineering Research Center for Biobank and Advanced Medical Research, The First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Road, Xi’an, Shaanxi 710061, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nLiu et al. BMC Cancer (2025) 25:1059  \nBackground  \nType 2 diabetes mellitus (T2DM) and cancer are major global public-health concerns. In the next two decades, the global burden of both diseases will rise by approximately 60% [1]. In 2022 alone, nearly 20 million new cases and 9.7 million deaths [2] were reported, while in 2021, around 537 million adults had diabete","cbCaisHrMus47prU","https://ap.wps.com/l/cbCaisHrMus47prU","pdf",1539617,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Study Rationale\n## Global burden and epidemiology\n## Known associations with cancer types\n## Potential pathophysiological mechanisms","[{\"question\":\"What was the goal of the retrospective cohort study?\",\"answer\":\"To investigate how cancer cases are distributed among patients with type 2 diabetes and identify associated risk factors that could inform clinical practice.\"},{\"question\":\"How many T2DM patients were analyzed, and how long were they followed?\",\"answer\":\"Electronic medical records of 70,073 patients were screened; 3,284 were included after exclusions, with a median follow-up of 27 months.\"},{\"question\":\"Which biomarkers were linked to cancer risk in the multivariable analysis?\",\"answer\":\"Lower serum uric acid levels and a higher AST/ALT ratio were associated with cancer risk among T2DM patients, with cancer-type-specific factors also reported.\"}]","Risk factors for cancer among patients with type 2 diabetes - a retrospective cohort study | PDF",1790189710,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4891ec0d7d15a6836a0f51ef6aee8bd7.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df8e1b8762cac985b820aa70ee7b44ef.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21abe22fc8486e17d8e912e84da01680.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/004e07028682445d2af6919ad917ba87.webp",980,1306]